Cyberknife Radiosurgery and Quality of Life
Trial ID or NCT#
NCT01163539
Status
NOT RECRUITING
Purpose
The purpose of this study is to look at pain control and QOL improvement after treatment with CK Radiosurgery for spinal metastases.
Official Title
Cyberknife Radiosurgery and Quality of Life
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
- * Patients with a spinal metastasis who will be treated with Cyberknife radiosurgery.* There are no age or gender restrictions.* There are no life expectancy restrictions.* Karnofsky Performance Status greater than 40.* Negative pregnancy test or clinically assessed as not pregnant.* Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
- * Patients with benign tumors will not be included (neurofibromas, schwannomas, etc.)* Other investigational medications or treatments will be noted, but will not preclude inclusion.* Pregnant or nursing patients will be not be included in the study due to radiation exposure.
Investigator(s)
Steven D. Chang, MD
Neurosurgeon,
Aneurysm neurosurgeon,
Cerebrovascular neurosurgeon,
Pituitary tumors neurosurgeon,
Stereotactic neurosurgeon
Robert C. and Jeannette Powell Neurosciences Professor and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences
Contact us to find out if this trial is right for you.
Contact
ccto-office@stanford.edu
650-498-7061
View on